RxDoctor Payments DataLook up a doctor →

NovoSeven: payments to doctors

Payments that named NovoSeven as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$583K
Providers
463
Transactions
942
Average per transaction
$619

The per-transaction average — $619 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 463 providers the average total is $1,260, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk$442,80875.9%
Novo Nordisk Health Care AG$90,03515.4%
Novo Nordisk AS$50,4568.7%
← All drugs & devices